Kaposi sarcoma herpesvirus viral load as a biomarker for leptomeningeal involvement by primary effusion lymphoma

Kathryn Lurain; Ramya Ramaswami; Vickie Marshall; Elena M Cornejo Castro; Nazzarena Labo; Wendell Miley; Kyle Moore; Romin Roshan; Ralph Mangusan; Elaine S Jaffe; Stefania Pittaluga; Hao-Wei Wang; Mark Roth; Armando C Filie; Thomas S Uldrick; Denise Whitby; Robert Yarchoan

doi:10.3324/haematol.2022.281472

Kaposi sarcoma herpesvirus viral load as a biomarker for leptomeningeal involvement by primary effusion lymphoma

Haematologica. 2023 Jul 1;108(7):1940-1944. doi: 10.3324/haematol.2022.281472.

Authors

Kathryn Lurain¹, Ramya Ramaswami², Vickie Marshall³, Elena M Cornejo Castro³, Nazzarena Labo³, Wendell Miley³, Kyle Moore³, Romin Roshan³, Ralph Mangusan², Elaine S Jaffe⁴, Stefania Pittaluga⁴, Hao-Wei Wang⁴, Mark Roth⁴, Armando C Filie⁴, Thomas S Uldrick², Denise Whitby³, Robert Yarchoan²

Affiliations

¹ HIV and AIDS Malignancy Branch, Center for Cancer Research (CCR), NCI, Bethesda, MD. kathryn.lurain@nih.gov.
² HIV and AIDS Malignancy Branch, Center for Cancer Research (CCR), NCI, Bethesda, MD.
³ Viral Oncology Section, AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD.
⁴ Laboratory of Pathology, CCR, NCI, Bethesda, MD.

No abstract available

Publication types

Letter

MeSH terms

Biomarkers
Herpesvirus 8, Human*
Humans
Lymphoma, Primary Effusion* / diagnosis
Sarcoma, Kaposi* / diagnosis
Sarcoma, Kaposi* / pathology
Viral Load

Substances

Biomarkers

Grants and funding

Funding: This research was supported by the Intramural Research Program of the NIH, National Cancer Institute and by US federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. 75N91019D00024/HHSN261200800001E.